[Pharmacology of hydrazinocarbonic acids, hydrazinopeptides and other hydrazine derivatives. VI. Influence of carbonic anhydrase inhibitors upon the toxicity of hydrazine derivatives].
D000086:Acetazolamide / Q000494:pharmacology; D000641:Ammonia / Q000494:pharmacology; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects; D002740:Chlorothiazide / Q000037:antagonists & inhibitors; D004336:Drug Antagonism; D004357:Drug Synergism; D005972:Glutaminase; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology* / Q000633:toxicity; D006898:Hydroxylamines / Q000633:toxicity; D010455:Peptides / Q000494:pharmacology; D013424:Sulfanilamides / Q000494:pharmacology; D013448:Sulfobromophthalein / Q000494:pharmacology
D002257:Carbonic Anhydrase Inhibitors; D006834:Hydrazines; D006898:Hydroxylamines; D010455:Peptides; D013424:Sulfanilamides; D013448:Sulfobromophthalein; D000641:Ammonia; D002740:Chlorothiazide; D005972:Glutaminase; D000086:Acetazolamide
Zur Pharmakologie von Hydrazinokarbonsäuren, Hydrazinopeptiden und anderen Hydrazinderivaten. VI. Beeinflussung der Toxizität von Derivaten des Hydrazins durch Karboanhydrasehemmstoffe.